Charles Rotimi is a researcher who studies the etiology of complex diseases and health disparities and advocates for the inclusion of greater racial and ethnic diversity in genomic repositories. In the early 2000s, Rotimi spearheaded the recruiting of African communities for participation in the International HapMap Project. As director of the Center for Research on Genomics and Global Health, or CRGGH, at the National Institutes of Health, or NIH, Rotimi led governmental research on human genetic variation and patterns of disease. Rotimi is a founding member of the Human Heredity and Health in Africa, or H3Africa, initiative, which aims to increase the representation of African populations in global genetic studies. Through his epidemiological research, leadership in advocacy groups for the support of African scientists, and his collaboration in genomic diversity initiatives, Rotimi promotes racial and ethnic representation in genetic research, especially regarding the inclusion of African people and the African diaspora.

Launched in 2002, the International HapMap Project was a collaborative effort among scientists from around the world to create a map of common patterns of genetic variation in the human genome. HapMap stands for haplotype map. A haplotype is a stretch of DNA nucleotides, or letters, that individuals inherit as a block because they lie relatively close together along a chromosome. For any particular region of a chromosome, there may be multiple different haplotypes present among humans, each characterized by a slightly different DNA sequence. By collecting and sequencing the DNA of initially 270 individuals from several different geographic regions, HapMap scientists were able to identify common haplotypes that exist among those individuals, as well as reliable markers to distinguish them. That collection of haplotypes and identifying markers—the HapMap—provided a shortcut for researchers who wanted to identify associations between those inherited DNA variants and particular human traits, especially common, complex diseases like heart disease and cancer.